MURA
Mural Oncology Plc -Company Extends Cash Runway Projection Into Q1 2026 Through Operational Efficiencies
时间：2025-01-10 05:42:17 市场： 综合 美股
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in Its Artistry-1 Clinical Trial of Nemvaleukin, Its Lead Engineered Fusion Protein, in the Journal for Immunotherapy of Cancer
时间：2024-11-21 05:15:00 市场： 美股 综合
Mural Oncology Plc Files for Mixed Shelf Offering of up to $300 Mln- SEC Filing
时间：2024-11-14 05:08:42 市场： 美股 综合
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
时间：2024-11-13 20:00:04 市场： 美股 综合
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
时间：2024-11-05 05:15:00 市场： 美股 综合
Mural Oncology Strengthens Board of Directors With the Appointment of Sachiyo Minegishi
时间：2024-09-23 19:00:01 市场： 美股 综合